Evidence map›Paper›PMID 34466438›Full record

ArticleGalen medical journal2018

Prediction of

Nasrin Amiri Dashatan, Mostafa Rezaie Tavirani, Hakimeh Zali, Mehdi Koushki, Nayebali Ahmadi

Open access · greenAbstract read
In one paragraph

Article in Galen medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Discovery of Novel Pyruvate Kinase Inhibitors AgainstTurkish journal of pharmaceutical sciences · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Barrett's esophagus transits to a cancer condition via potential biomarkers.Gastroenterology and hepatology from bed to bench · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nasrin Amiri DashatanProteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mostafa Rezaie TaviraniProteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hakimeh ZaliAdvanced Technologies in Medicine. Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mehdi KoushkiDepartment of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Nayebali AhmadiProteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shahid Beheshti University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough leishmaniasis is regarded as a public health problem, no effective vaccine or decisive treatment has been introduced for this disease. Therefore, representing novel therapeutic proteins is essential. Protein-protein Interaction network analysis is a suitable tool to discover novel drug targets for MATERIALS AND

methodsIn this computational and bioinformatics study, the protein/gene expression data related to

resultsBased on gene ontology analysis, most of the

conclusionThe results indicated that hub proteins play a significant role in pathogenesis and life cycle of

Indexed as

Centrality AnalysisGene Ontologyleishmania majorLeishmaniasisProtein Interaction Networks

Identifiers

PMID34466438
PMCPMC8344062
OpenAlexW3196968449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.